In addition to salivary Aβ levels, five out of ten studies on saliva biomarkers for AD aimed to determine the levels of hyperphosphorylated tau (p-tau) or total tau protein (t-tau) [19,21,25,26,27] (Table 2). This evidence concerns the gene MAPT and Alzheimer disease.